Viveve Medical Stock

Viveve Medical EBIT 2024

Viveve Medical EBIT

-14.32 M USD

Ticker

VIVE

ISIN

US92852W5013

WKN

A2QJQB

In 2024, Viveve Medical's EBIT was -14.32 M USD, a -30.25% increase from the -20.53 M USD EBIT recorded in the previous year.

The Viveve Medical EBIT history

YEAREBIT (undefined USD)
2026e-20,890.15
2025e-18,005.97
2024e-14,320.8
2023e-20,532.6
2022e-20,930.4
2021-21,553
2020-18,500
2019-29,930
2018-44,970
2017-33,730
2016-18,700
2015-11,990
2014-5,660
2013-3,930
2012-4,130
2011-3,410
2010-3,210
2009-1,630
2008-2,110
2007-2,810
2006-520
2005-1,520
2004-960
2003710
2002230

Viveve Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Viveve Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Viveve Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Viveve Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Viveve Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Viveve Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Viveve Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Viveve Medical’s growth potential.

Viveve Medical Revenue, EBIT and net profit per share

DateViveve Medical RevenueViveve Medical EBITViveve Medical Net Income
2026e45.22 M undefined-20.89 M undefined-19.89 M undefined
2025e34.88 M undefined-18.01 M undefined-14.38 M undefined
2024e22.33 M undefined-14.32 M undefined-10.61 M undefined
2023e11.36 M undefined-20.53 M undefined-17.5 M undefined
2022e7.03 M undefined-20.93 M undefined-27.88 M undefined
20216.43 M undefined-21.55 M undefined-26.72 M undefined
20205.48 M undefined-18.5 M undefined-26.06 M undefined
20196.57 M undefined-29.93 M undefined-42.91 M undefined
201818.52 M undefined-44.97 M undefined-49.98 M undefined
201715.29 M undefined-33.73 M undefined-36.96 M undefined
20167.14 M undefined-18.7 M undefined-20.11 M undefined
20151.45 M undefined-11.99 M undefined-12.43 M undefined
201490,000 undefined-5.66 M undefined-6.18 M undefined
2013150,000 undefined-3.93 M undefined-4.32 M undefined
20121.08 M undefined-4.13 M undefined-8.39 M undefined
2011670,000 undefined-3.41 M undefined-5.76 M undefined
2010590,000 undefined-3.21 M undefined-510,000 undefined
20094.71 M undefined-1.63 M undefined-1.63 M undefined
20085.33 M undefined-2.11 M undefined-1.94 M undefined
20076 M undefined-2.81 M undefined-2.37 M undefined
20067.15 M undefined-520,000 undefined1.32 M undefined
20057.64 M undefined-1.52 M undefined-1.27 M undefined
20047.57 M undefined-960,000 undefined-830,000 undefined
20038.33 M undefined710,000 undefined520,000 undefined
20028.84 M undefined230,000 undefined310,000 undefined

Viveve Medical stock margins

The Viveve Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Viveve Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Viveve Medical.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Viveve Medical's sales revenue. A higher gross margin percentage indicates that the Viveve Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Viveve Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Viveve Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Viveve Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Viveve Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Viveve Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Viveve Medical Margin History

Viveve Medical Gross marginViveve Medical Profit marginViveve Medical EBIT marginViveve Medical Profit margin
2026e9.65 %-46.2 %-43.99 %
2025e9.65 %-51.63 %-41.24 %
2024e9.65 %-64.14 %-47.5 %
2023e9.65 %-180.7 %-153.96 %
2022e9.65 %-297.81 %-396.74 %
20219.65 %-335.4 %-415.78 %
20205.47 %-337.59 %-475.55 %
201915.53 %-455.56 %-653.12 %
201839.52 %-242.82 %-269.87 %
201748.66 %-220.6 %-241.73 %
201635.43 %-261.9 %-281.65 %
201531.72 %-826.9 %-857.24 %
201444.44 %-6,288.89 %-6,866.67 %
2013-20 %-2,620 %-2,880 %
201250 %-382.41 %-776.85 %
201137.31 %-508.96 %-859.7 %
2010-11.86 %-544.07 %-86.44 %
200955.41 %-34.61 %-34.61 %
200858.72 %-39.59 %-36.4 %
200756.17 %-46.83 %-39.5 %
200661.68 %-7.27 %18.46 %
200559.82 %-19.9 %-16.62 %
200459.45 %-12.68 %-10.96 %
200359.9 %8.52 %6.24 %
200253.73 %2.6 %3.51 %

Viveve Medical Aktienanalyse

What does Viveve Medical do?

Viveve Medical Inc. is a company specializing in the development of medical technology. The company is based in Englewood, Colorado, USA, and has been listed on the NASDAQ exchange since 2005. Viveve was founded to meet the needs of women in improving their physical health. The company has developed an innovative technology that allows women to maintain their vaginal health. History of Viveve Medical Inc. Viveve Medical Inc. was founded by an experienced team of physicians and engineers. The company was launched by Dr. William Doyle and a group of experts with extensive experience in the field of medical technology. Dr. Doyle brought his experience in developing technologies to improve skin structure and firmness to the company. The technical expertise of the other team members helped in the development of devices that can improve women's vaginal health. Business model of Viveve Medical Inc. Viveve Medical Inc. is an innovative company that aims to improve women's vaginal health. Viveve's products are based on the patented radiofrequency technology developed by the company. The technology is used in a device called the Viveve System, which is used by medical professionals to help women of different ages in the treatment of pelvic disorders and problems. The company has marketed its products in over 50 countries worldwide. It also collaborates with local distributors and other medical device manufacturers to promote and sell its products on the market. Viveve Medical Inc. offers innovative technologies such as the Viveve System, which allow women to improve their vaginal health and enhance their well-being. The company has various divisions, including medical technology, pharmacy, and medical services. Each division has a different mission and offers different products and services. Products of Viveve Medical Inc. Viveve Medical Inc. has launched several products that aim to improve women's vaginal health. The company's main product is the Viveve System, a device used in the treatment of pelvic disorders and problems. The device utilizes Viveve's patented radiofrequency technology to increase collagen production in tissue. This allows the Viveve System to combat vaginal laxity and incontinence. The Viveve System should always be used by trained medical professionals. In addition to the Viveve System, the company offers other products to improve women's physical health. This includes hormonal therapies that help with hormonal system disorders and alleviate vaginal dryness and pain, as well as surgical interventions for the treatment of irregularities in the female reproductive system. In the pharmaceutical division, the company has effective medications such as kisspeptin in the developmental stage, prescribed for increasing libido in women. Conclusion Overall, Viveve Medical Inc. is a company dedicated to improving women's vaginal health. The company has the innovative technology of the Viveve System and also offers a variety of products and services to enhance women's well-being. Viveve Medical Inc. is a key player in the field of medical technology, providing solutions for a variety of issues. Viveve Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Viveve Medical's EBIT

Viveve Medical's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Viveve Medical's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Viveve Medical's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Viveve Medical’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Viveve Medical stock

How much did Viveve Medical achieve in EBIT for the current year?

In the current year, Viveve Medical has achieved an EBIT of -14.32 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Viveve Medical.

How has the EBIT of Viveve Medical developed in recent years?

The EBIT of Viveve Medical has increased by -30.253% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Viveve Medical?

The EBIT of Viveve Medical is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Viveve Medical pay?

Over the past 12 months, Viveve Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Viveve Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Viveve Medical?

The current dividend yield of Viveve Medical is .

When does Viveve Medical pay dividends?

Viveve Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Viveve Medical?

Viveve Medical paid dividends every year for the past 0 years.

What is the dividend of Viveve Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Viveve Medical located?

Viveve Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Viveve Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Viveve Medical from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Viveve Medical pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Viveve Medical in the year 2023?

In the year 2023, Viveve Medical distributed 0 USD as dividends.

In which currency does Viveve Medical pay out the dividend?

The dividends of Viveve Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Viveve Medical

Our stock analysis for Viveve Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Viveve Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.